ClinicalTrials.Veeva

Menu

Improvement of Hemostasis Techniques After Median Sternotomy

A

Aarhus University Hospital

Status and phase

Unknown
Phase 4

Conditions

Sternal Infection
Sternal Dehiscence
Sternal Pain

Treatments

Device: Ostene
Device: Bonewax

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01134471
Ostene-project

Details and patient eligibility

About

The purpose of this study is to compare 2 different hemostatic agents (Bonewax and Ostene)to a control group with regards to bleeding, bone healing, pain and infection in a patient group all undergoing median sternotomy.

Enrollment

75 patients

Sex

Male

Ages

60 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • men undergoing elective cardiac surgery at the Cardiac surgery department of Aarhus University Hospital, Skejby
  • no clopidogrel-treatment
  • no osteoporoses
  • less than 2 co-morbidities in the form of obesity (BMI>30), COPD, chronic steroid use, renal failure, immunosuppression and diabetes

Exclusion criteria

  • profuse sternal bleeding
  • serious complications to the surgery fx cerebral infarction
  • re-operation due to bleeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

75 participants in 3 patient groups

Control
No Intervention group
Bonewax
Active Comparator group
Description:
Patients treated with the hemostatic bonewax
Treatment:
Device: Bonewax
Ostene
Active Comparator group
Description:
Patients treated with the hemostatic Ostene
Treatment:
Device: Ostene

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems